The Pennant Group, Inc. (NASDAQ:PNTG) Stock Position Reduced by Price T Rowe Associates Inc. MD

Price T Rowe Associates Inc. MD trimmed its position in The Pennant Group, Inc. (NASDAQ:PNTG) by 36.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 35,946 shares of the company’s stock after selling 20,688 shares during the quarter. Price T Rowe Associates Inc. MD owned approximately 0.10% of The Pennant Group worth $954,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Summit Investment Advisors Inc. increased its stake in The Pennant Group by 20.3% during the fourth quarter. Summit Investment Advisors Inc. now owns 3,414 shares of the company’s stock valued at $91,000 after purchasing an additional 575 shares during the last quarter. Corebridge Financial Inc. raised its stake in The Pennant Group by 6.2% during the fourth quarter. Corebridge Financial Inc. now owns 16,227 shares of the company’s stock worth $430,000 after acquiring an additional 954 shares during the period. Arizona State Retirement System lifted its holdings in The Pennant Group by 13.0% in the fourth quarter. Arizona State Retirement System now owns 9,773 shares of the company’s stock worth $259,000 after acquiring an additional 1,121 shares during the last quarter. Hillsdale Investment Management Inc. boosted its stake in The Pennant Group by 0.6% in the fourth quarter. Hillsdale Investment Management Inc. now owns 190,882 shares of the company’s stock valued at $5,062,000 after acquiring an additional 1,200 shares during the period. Finally, Principal Financial Group Inc. grew its holdings in shares of The Pennant Group by 10.9% during the fourth quarter. Principal Financial Group Inc. now owns 14,000 shares of the company’s stock valued at $371,000 after purchasing an additional 1,374 shares during the last quarter. 85.88% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

PNTG has been the topic of several recent research reports. Truist Financial cut their price target on The Pennant Group from $32.00 to $28.00 and set a “hold” rating on the stock in a report on Friday, March 7th. Stephens reissued an “overweight” rating and set a $38.00 price target on shares of The Pennant Group in a report on Wednesday, April 2nd. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, The Pennant Group has an average rating of “Moderate Buy” and a consensus price target of $34.80.

The Pennant Group Stock Up 0.8 %

Shares of The Pennant Group stock opened at $28.40 on Friday. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.12 and a quick ratio of 1.12. The Pennant Group, Inc. has a 1-year low of $21.18 and a 1-year high of $37.13. The business’s fifty day moving average price is $25.04 and its two-hundred day moving average price is $27.37. The company has a market capitalization of $986.10 million, a P/E ratio of 41.77, a PEG ratio of 2.24 and a beta of 1.56.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.